[Retracted] Improved ataxia telangiectasia mutated kinase inhibitor KU60019 provides a promising treatment strategy for non-invasive breast cancer. [PDF]
Zhu Y +8 more
europepmc +1 more source
Ataxia-Telangiectasia in Resource-Limited Settings: A Diagnostic Challenge. [PDF]
Adeyemi E +4 more
europepmc +1 more source
Ataxia telangiectasia mutated (ATM) kinase as a predictive biomarker in clinical oncology: implications for a precision treatment approach. [PDF]
Pham AT +3 more
europepmc +1 more source
Intractable thrombocytopenia in a patient with atypical ataxia-telangiectasia: a case report. [PDF]
Gu C +5 more
europepmc +1 more source
Long-Term Follow-Up for Child with Ataxia Telangiectasia Related Scoliosis Using Surface Topography: A Case Report. [PDF]
Wagner B, Thiessen A, Liu XC.
europepmc +1 more source
Systematic review of hematopoietic stem cell transplantation in patients with ataxia telangiectasia: a case report and an individual patient-level analysis. [PDF]
Bekis Bozkurt H +10 more
europepmc +1 more source
Impact of ataxia-telangiectasia mutated (ATM) loss on radiobiological and immune response to radium-223 in prostate cancer <i>in vitro</i> models. [PDF]
Dunne VL +6 more
europepmc +1 more source
Computational modeling of ATM signaling: a predictive framework for drug repurposing in ataxia-telangiectasia. [PDF]
Merulla AE +7 more
europepmc +1 more source
MRI and Biomarkers in Early Detection of Pulmonary Changes in Ataxia-Telangiectasia. [PDF]
Grzywa-Czuba R +4 more
europepmc +1 more source
Nutritional status and metabolic alterations in patients with ataxia-telangiectasia. [PDF]
de Leon CDA +69 more
europepmc +1 more source

